BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine.
Miller AL, Fehling SC, Vance RB, Chen D, Brown EJ, Hossain MI, Heard EO, Andrabi SA, Wang H, Yang ES, Buchsbaum DJ, van Waardenburg RCAM, Bellis SL, Yoon KJ.
Miller AL, et al. Among authors: yoon kj.
Cancer Lett. 2024 Jun 28;592:216919. doi: 10.1016/j.canlet.2024.216919. Epub 2024 May 3.
Cancer Lett. 2024.
PMID: 38704133